Cardiff Lexington signs LOI to buy musculoskeletal healthcare platform for up to $104 million
CDIX•Cardiff Lexington signed a letter of intent to acquire a multi-state musculoskeletal healthcare platform for up to $104 million. The proposed deal includes $30 million in cash at closing, $10 million in unsecured notes and other contingent consideration.
1. Proposed deal terms
The sellers would receive preferred equity valued to equal 35% of fully diluted equity after closing, with potential conversion above a $120 million valuation. An earnout of up to $12 million in common stock would depend on EBITDA thresholds for 2027, 2028 and 2029. Closing is targeted for Nov. 16, 2026, subject to due diligence, financing and definitive agreements.
